Posts by Sandra Ansanay-Alex
Debiopharm invests in Digital Health
Debiopharm’s strategic corporate fund invests in digital health, smart data & innovative tech start-ups The fund typically invests in Serie A and B rounds, between CHF 3 to 5 million. Smart Data Companies that leverage medical data and AI to have an impact on either the patient journey or the development of pharmaceutical…
Read MoreCordis spends 1.14 billion francs to buy MedAlliance
Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis for 1.14 billion francs. Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of…
Read MoreNetsensing Technology finalists of the 14th Healthcare Innovation World Cup at Medica 2022
Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12 Health Techpreneurs 2022. Netsensing Technology is presenting its solution in an exciting final during the 14th Healthcare Innovation World Cup® Pitch and Award Ceremony at MEDICA in Dusseldorf, the world’s largest medical trade fair…
Read MoreInterview Denis Cavin
Why is Western Switzerland is a perfect place for lifesciences companies? Listen to Denis Cavin, Economic Development Officer at State of Geneva ✅ Collaboration between academic institutions and industries ✅ A strong #education system that creates a pool of talent for highly qualified jobs ✅ Political and economic stability ✅ The World Health Organization in Geneva, attracts a lot…
Read MoreOculis to go public
The Lausanne-based company Oculis SA, and European Biotech Acquisition Corp, announced a business combination agreement to create a Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology Upon closing of the transaction, the company will be named “Oculis Holding SA” and will work to accelerate the development of Oculis’s differentiated ophthalmology pipeline. The transaction includes…
Read MoreSUN Bioscience receives an EPFL Alumni Awards
The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of their careers. Nathalie Brandenberg and Sylke Hoehnel co-founded SUN bioscience in 2016. SUN bioscience offers a 3D microwell platform based on patient-specific organoids. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are…
Read MoreFirmenich inaugurates its new campus in Geneva
The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of 61,000 tonnes per year. It is the largest of the group’s global operations and one of the most technologically advanced. “This investment of nearly CHF 200 million is the most important one Firmenich has…
Read MoreORamaVR raises 2.4M EUR in a post-seed funding round
The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the training of medical professionals on a large scale The lack of access to affordable surgical care today has created a major health crisis currently affecting almost 5 billion people globally. The World Health Organization…
Read MoreBoneView®, an AI solution to improve fractures diagnostic on X-rays images
Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on X-Ray images. Healthcare Konnect, a Swiss company dedicated to the distribution of AI-based diagnostic solutions and Gleamer, a French MedTech company that develops a suite of Artificial Intelligence products for radiology, have announced a…
Read MoreRon Appel, SIB’s president, retires
Bioinformatics pioneer gives way to the next generation Ron Appel pioneered the field of bioinformatics in Switzerland and supported the remarkable growth of the discipline over the years, with SIB becoming one of the world’s leading institutes in the field. Co-founder of SIB in 1998, Ron Appel became its Executive Director in 2007. He then shared…
Read More